Publication at First Faculty of Medicine |
2012
Abstract
Eculizumab is a recombinant humanized monoclonal antibody against the C5 complement, of which blockade prevents the complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH) ...